e-Drug3D 102 |
BROMODIPHENHYDRAMINE DISCONTINUED
|
cas 1808-12-4 |
CLASS DERMATOLOGICALS |
ROUTE (list) ORAL |
PK parameters |
Target TARGET HISTAMINE H1 RECEPTOR |
DrugCentral Histamine H1 receptor UNIPROT P35367 HRH1 |
Download SDF file | 2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine Formula: Calculated chemical properties: MW 334.24 NB_atoms 20 XLogP 4.12 PSA 14.417 NB_HD 0 NB_HA 2 fsp3 0.29 Lipinski(0=no;1=yes) 1 |
FDA NDA 007984 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE) AMBODRYL (PARKE DAVIS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 088343 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE ; CODEINE PHOSPHATE) BROMANYL (ALPHARMA US PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 009319 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE ; CODEINE PHOSPHATE) AMBENYL (FOREST LABS) APPROVAL= AP YEAR= 1954 DISCONTINUED NDA 088626 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE ; CODEINE PHOSPHATE) BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE (WOCKHARDT) APPROVAL= AP YEAR= 1984 DISCONTINUED |
Other links: |